# Align Technology, Inc. (ALGN)

**Exchange:** NASDAQ  
**Sector:** Healthcare  
**Market cap:** $12.38B  
**Price:** $170.50 (-4.27%)

> Align Technology, Inc. is a medical device company specializing in digital orthodontics and restorative dentistry solutions. Its primary business centers on clear aligner therapy through the Invisalign product family, which is used to treat a wide range of malocclusion cases in collaboration with trained dentists and orthodontists worldwide. The company also operates a Systems and Services segment built around its iTero intraoral scanners and related software, providing digital scanning, treatment visualization, and integrated workflows for dental practices and laboratories. This includes hardware platforms, orthodontic and restorative software options, subscription services, upgrades, disposables, and CAD/CAM software from exocad that links practices to dental labs. Together, these products position Align Technology as a key player in the shift toward digital, chairside, and impressionless dentistry. Founded in 1997 and headquartered in Tempe, Arizona, Align Technology serves dental professionals globally across the healthcare and medical instruments and supplies sector.

## Income Statement (Annual, USD)

| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (dil.) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $4.03B | $2.71B | $546M | $410M | — |
| 2024 | $4.00B | $2.80B | $608M | $421M | — |
| 2023 | $3.86B | $2.71B | $643M | $445M | — |
| 2022 | $3.73B | $2.63B | $643M | $362M | — |
| 2021 | $3.95B | $2.94B | $976M | $772M | — |
| 2020 | $2.47B | $1.76B | $387M | $1.78B | — |
| 2019 | $2.41B | $1.74B | $542M | $443M | — |
| 2018 | $1.97B | $1.45B | $467M | $400M | — |
| 2017 | $1.47B | $1.12B | $354M | $231M | — |
| 2016 | $1.08B | $815M | $249M | $190M | — |
| 2015 | $845M | $640M | $189M | $144M | — |
| 2014 | $762M | $578M | $194M | $146M | — |
| 2013 | $660M | $498M | $94M | $64M | — |
| 2012 | $560M | $416M | $86M | $59M | — |
| 2011 | $480M | $361M | $90M | $67M | — |

## Balance Sheet (Annual, USD)

| Fiscal Year | Total Assets | Total Liabilities | Equity | Cash | Long-term Debt |
| --- | --- | --- | --- | --- | --- |
| 2025 | $6.23B | $2.18B | $4.05B | $1.09B | — |
| 2024 | $6.21B | $2.36B | $3.85B | $1.04B | — |
| 2023 | $6.08B | $2.45B | $3.63B | $937M | — |
| 2022 | $5.95B | $2.35B | $3.60B | $942M | — |
| 2021 | $5.94B | $2.32B | $3.62B | $1.10B | — |
| 2020 | $4.83B | $1.60B | $3.23B | $961M | — |
| 2019 | $2.50B | $1.15B | $1.35B | $550M | — |
| 2018 | $2.05B | $800M | $1.25B | $637M | — |
| 2017 | $1.78B | $630M | $1.15B | $450M | — |
| 2016 | $1.40B | $401M | $999M | $389M | — |
| 2015 | $1.16B | $311M | $848M | $168M | — |
| 2014 | $988M | $235M | $753M | $200M | — |
| 2013 | $832M | $198M | $634M | $243M | — |
| 2012 | $756M | $175M | $581M | $306M | — |
| 2011 | $649M | $158M | $491M | $306M | — |

## Cash Flow (Annual, USD)

| Fiscal Year | Operating Cash Flow | CapEx | Free Cash Flow |
| --- | --- | --- | --- |
| 2025 | $593M | $102M | $491M |
| 2024 | $738M | $116M | $623M |
| 2023 | $786M | $178M | $608M |
| 2022 | $569M | $292M | $277M |
| 2021 | $1.17B | $401M | $771M |
| 2020 | $662M | $155M | $507M |
| 2019 | $747M | $150M | $598M |
| 2018 | $555M | $223M | $331M |
| 2017 | $439M | $196M | $243M |
| 2016 | $248M | $71M | $177M |
| 2015 | $238M | $53M | $185M |
| 2014 | $227M | $24M | $203M |
| 2013 | $186M | $19M | $167M |
| 2012 | $134M | $38M | $95M |
| 2011 | $130M | $30M | $100M |

Source: [CompaniesByCap](https://companiesbycap.com/company/ALGN)